With 25 years of innovation, Ambry is the recognized leader in germline testing, with solutions to support pharma partners throughout the therapeutic development process. We offer an extensive menu of CLIA-validated panels for indications including Oncology, Cardiology, Neurology, and other Rare Diseases. Test customization ensures your assay is fit for purpose, with options for tailored Exome testing and Whole Genome Sequencing. We provide robust analytical assay validation as well as clinical validation, to help advance your therapy from bench to clinic. #Ambry25 #AmbryPharmaServices
Ambry Genetics
Biotechnology Research
Aliso Viejo, CA 71,113 followers
Finding Answers Through Quality Genetic Testing
About us
Ambry Genetics is a company built by scientists, genetic counselors and physicians, dedicated to leading the clinical genomic diagnostic industry. Ambry boasts the largest genetic sequencing lab in the world; is CAP-accredited, CLIA-licensed and, as part of the Konica Minolta family, has access to the most complete suite of diagnostic technology in the world. Ambry Genetics' scope of clients includes some of the world's most respected academic institutions, pharmaceutical companies and leading treatment hospitals. Our experience, technology and dedication to science make us a trusted source for all clinical genetic testing, and an ideal partner for developing precision medicine solutions. Patients are at the core of everything we do, which is why Ambry partners with several non-profit organizations so that we can help both patients and clinicians alike find answers. Hiring Fraud Alert: Ambry/REALM IDx has received reports of employment scams in recent months that seek financial commitments, or requests personal information from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) posing to be or represent Ambry/REALM IDx recruiter(s). If you’ve experienced either of these scenarios, please visit this page to learn more about hiring fraud: https://consumer.ftc.gov/articles/job-scams. Or visit https://realmidx.com/careers/recruitment-fraud-alert/ to learn more about our policy on recruitment fraud. You can confirm the legitimacy of a job posting by viewing our current open roles at https://realmidx.com/careers/.
- Website
-
https://www.ambrygen.com
External link for Ambry Genetics
- Industry
- Biotechnology Research
- Company size
- 501-1,000 employees
- Headquarters
- Aliso Viejo, CA
- Type
- Privately Held
- Founded
- 1999
- Specialties
- Molecular Diagnostic Testing, Clinical Diagnostic Exome, Breast Cancer Genetics, Hereditary Cancer, Cardio Genetics, Neuro Genetics, General Genetics, Family History Questionnaire, Pedigree Drawing Tool, and Risk Assessment Tool
Locations
-
Primary
1 Enterprise
Aliso Viejo, CA 92656, US
-
7 Argonaut
Aliso Viejo, CA 92656, US
Employees at Ambry Genetics
Updates
-
We asked everyone at Ambry to describe the genetic counselors they work with with three words or phrases. Check out their responses and comment your own! #Ambry25 #genechat #genetictesting #geneticcounselor #experiencematters #NSGC2024
-
Calling all oncology genetic counselors! Be sure to visit us at Ambry Booth 301 to be among the first to hear about how we’re shaking it up with some show-stopping updates in hereditary cancer testing. #genetictesting #NSGC24 #SettingtheStandard #ExperienceMatters
-
We are having a great time at #NSGC24, meeting up with friends, both old and new! Our 25th anniversary gnome is exploring the city. You may see him out and about in New Orleans, but you can find your own at booth 301. #Ambry25 #AmbryGnomes #GnomesinNewOrleans #RNAEra
-
Don't miss the Innovations in Genetic Testing Lunch Symposium Thursday at NSGC! Join Ambry presenters Carrie Horton, Senior Medical Liaison and Clinical Researcher, and Jennifer Herrera-Mullar, Principal Clinical Scientist, and guest speaker, Dr. Tuya Pal, a board certified clinical geneticist and researcher from the Vanderbilt-Ingram Cancer Center, for an in-depth look at how Ambry Genetics approaches the design of genetic testing menus and panels, emphasizing gene-disease validity, clinical utility, and the evolving landscape of clinical testing. #NSGC2024 #Ambry25
-
2024 has already seen promising discoveries in precision oncology and new identifications of gene-disease validity. As we celebrate 25 years of serving patients, we have been looking back at the industry milestones that led us here. We have to thank "The Father of Genetics" for starting this journey with his pea-plant experiments. We look forward to continued innovation in the years ahead! Here's to sharing many more milestones together. Stop by booth 301 at #NSGC24 to meet this new member of the family. #Ambry25 #AmbryGnomes
-
Ambry is in The Big Easy. Stop by booth 301 and celebrate our 25th anniversary with us and join us in our RNA Era! We can't wait to see you there! #genetictesting #raredisease #exome #hereditarycancer #Ambry25 #NSGC24 #GeneChat
-
How can you get your very own exclusive RNA Era T-shirt? Easy! Interact on social media, get a shirt! Simply post a picture or a memory from the last 25 years with Ambry or an insight from #NGSC24 with the hashtag #Ambry25 (tag @AmbryGenetics on LinkedIn, Facebook, and X) and then visit Ambry booth 301 on Thursday, September 19 between 4:30 and 6:30. (While supplies last).
-
From genetic testing to RNA analysis to exome updates with Patient for Life™, the Gene Explorer Gnome reflects Ambry's “no stone left unturned” commitment to find answers for patients. In 2023, we shared a milestone publication that showed the utility of RNA testing for hereditary cancer (the largest study of its kind!). We continue to uncover new treasures with ExomeReveal™, which gains an additional 2% from RNA analysis and 5% from the Patient for Life, for an overall 20% higher diagnostic yield compared to standard exome testing. #Ambry25 #AmbryGnomes
-
We’re so excited to share the launch of our new ExomeReveal™️ product at NSGC in New Orleans. Our experts will be on hand to share more about how exome testing has entered its RNA era. #Exome #ExperienceMatters #NSGC2024 Stop by booth 301 to learn more.